financetom
Business
financetom
/
Business
/
What Happened With Canopy Growth Stock Today?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What Happened With Canopy Growth Stock Today?
Jul 16, 2024 2:44 PM

Canopy Growth Corporation ( CGC ) shares continued to move higher Tuesday after gaining more than 9% in Monday's session. Here's a look at what you need to know. 

What To Know: Canopy Growth ( CGC ) stock popped Monday around the same time former President Donald Trump selected Sen. J.D. Vance (R-Ohio) as his vice-presidential running-mate. Ohio legalized adult-use cannabis in November 2023.

According to a Marijuana Moment report, Vance believes states should set their own cannabis laws. He’s also suggested that he's against incarcerating individuals for low-level possession.

Vance voted against the Secure and Fair Enforcement Regulation (SAFER) Banking Act when it was approved in September 2023, noting that “the bill was crafted in such a way that actually would have opened up access to banking resources for fentanyl traffickers and others.” However, Vance left the door open to approving a revised bill in the future.

“If the legislation is better, I’d be more likely to support it,” he said at the time.

Read Next: Solar Stocks Tumble Following Failed Assassination Of Trump: What’s Going On?

What Else: The Czech government is reportedly pursuing a full commercial adult-use cannabis market as part of its Cannabis Management Act, according to a report released Monday from Business of Cannabis. Canopy Growth ( CGC ) currently serves the medical marijuana market in the Czech Republic.

Canopy Growth ( CGC ) still faces several headwinds, including the uncertain regulatory environment in the U.S., and the company has yet to become profitable. According to data from Benzinga Pro, Canopy Growth ( CGC ) shares are trading below the stock’s 50-day moving average of $8.02. It’s also worth noting that approximately 17.5% of Canopy’s float is currently being sold short. 

Will CGC Stock Go Up?

When trying to assess whether or not Canopy Growth ( CGC ) will trade higher from current levels, it's a good idea to take a look at analyst forecasts.

Wall Street analysts have an average 12-month price target of $2 on Canopy Growth ( CGC ). One analyst has a negative rating on Canopy Growth’s stock.

In the last month, one analyst has adjusted price targets. Here's a look at recent price target changes [Analyst Ratings]. Benzinga also tracks Wall Street's most accurate analysts. Check out how analysts covering Canopy Growth ( CGC ) have performed in recent history.

Stocks don't move in a straight line. The average stock market return is approximately 10% per year. Canopy Growth ( CGC ) is 80.49% up year-to-date. The average analyst price target suggests the stock could have further downside ahead.

For a broad overview of everything you need to know about Canopy Growth ( CGC ), visit here. If you want to go above and beyond, there's no better tool to help you do just that than Benzinga Pro. Start your free trial today.

CGC Price Action: According to Benzinga Pro, Canopy Growth ( CGC ) shares ended Tuesday session 3.08% higher at $7.36.

Read Also:

What’s Going On With Upstart Stock?

Image: Nicky from Pixabay

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Eton Pharmaceuticals' New Drug Application for ET-600 Accepted for Review by FDA; Shares Rise Premarket
Eton Pharmaceuticals' New Drug Application for ET-600 Accepted for Review by FDA; Shares Rise Premarket
Jul 8, 2025
07:24 AM EDT, 07/08/2025 (MT Newswires) -- Eton Pharmaceuticals ( ETON ) said Tuesday that the US Food and Drug Administration has accepted for review its new drug application for ET-600. The company said ET-600 is its patented formulation of desmopressin oral solution for the treatment of central diabetes insipidius. The FDA has set a target action date of Feb....
GR Silver Mining Provides Initial Results From Sampling Program at Plomosas Mine in Mexico
GR Silver Mining Provides Initial Results From Sampling Program at Plomosas Mine in Mexico
Jul 8, 2025
07:23 AM EDT, 07/08/2025 (MT Newswires) -- GR Silver Mining ( GRSLF ) reported on Tuesday initial results of the phase one underground sampling program at the Plomosas mine in Mexico. Sampling highlights include 2,423 grams per tonne (g/t) silver equivalent, 0.8 meters at 2,019 g/t silver equivalent, and 0.6 meters at 3,993 g/t silver equivalent. GR Silver said its...
Top Premarket Gainers
Top Premarket Gainers
Jul 8, 2025
07:24 AM EDT, 07/08/2025 (MT Newswires) -- ENDRA Life Sciences ( NDRA ) shares were up 140% pre-bell Tuesday following a 2.4% loss in the previous session. BioSig Technologies ( BSGM ) shares were 30% higher after the company said late Monday it signed deals with an institutional investor for up to $1.1 billion in growth financing. Optical Cable (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved